ENOV Earnings Date: Nov 5, 2026 (Estimated) — Enovis Corporation
NYSE · Healthcare · Medical Devices
Updated
When is ENOV's next earnings date?
Enovis Corporation (ENOV) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.77 on revenue of $557.1M.
How did ENOV do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Enovis Corporation posted EPS of $0.90 versus the $0.85 estimate, a beat of 7.1%. Revenue was $582.8M against a $581.8M estimate. The stock's 1-day post-earnings move was -12.8%.
How much does ENOV stock move after earnings?
ENOV beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.6% (up or down) in the day after earnings.
About Enovis Corporation
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 0.85 | 0.90 | +7.14% | $582.8M | ✅ Beat | -12.82% | -18.19% | -35.72% |
| 2026-05-07 | Q1 2026 | 0.81 | 0.89 | +9.88% | $589.2M | ✅ Beat | +9.66% | +3.42% | -4.31% |
| 2026-02-26 | Q4 2025 | 0.83 | 0.95 | +14.46% | $575.8M | ✅ Beat | +13.89% | +15.55% | +4.70% |
| 2025-11-06 | Q3 2025 | 0.66 | 0.75 | +13.64% | $548.9M | ✅ Beat | -9.75% | -0.79% | -14.20% |
| 2025-02-26 | Q4 2024 | 0.92 | 0.98 | +6.52% | $561.0M | ✅ Beat | -4.99% | -13.02% | -6.94% |
| 2024-11-06 | Q3 2024 | 0.62 | 0.73 | +17.74% | $505.2M | ✅ Beat | +8.29% | +8.31% | +10.55% |
| 2024-08-07 | Q2 2024 | 0.60 | 0.62 | +3.33% | $525.2M | ✅ Beat | -3.36% | +3.05% | +2.69% |
| 2024-05-02 | Q1 2024 | 0.48 | 0.50 | +4.17% | $516.3M | ✅ Beat | -5.90% | -8.54% | -9.26% |
Showing last 8 quarters.